Researchers have presented a low cost track and trace and authentication system, which they believe could be implemented immediately, to combat counterfeiting in the developing world.
Europe is pulling ahead of the US in research productivity, according to a controversial new study by Washington public policy think tank Health Affairs.
Mantecorp is using the Control and Communication Link (CC-Link) open fieldbus network to improve the environmental credentials of its facility in Rio de Janeiro, Brazil.
Indian CRO Siro Clinpharm has set its sights on the European research market, signing a deal with UK based CambReg that it hopes will offer customers a path through the region’s complex regulations.
Source BioScience (SBS) is eyeing acquisitions and investments in technology after it posted a profit in the first six months of 2009, overturning a loss in the same period of last year.
The global protein therapeutics market will be worth $77bn by 2011 with biogenerics playing an increasingly important role, according to a new survey by industry analysts RNCOS.
UK drug major GSK says that two lots of its respiratory drug Advair Diskus have been stolen from a distribution facility in Richmond, Virginia in the US.
US analysis group CRL will set up a new laboratory at Quotient Bioresearch’s facility in Cambridge in the UK, in a collaboration designed to expand the US company’s business on the global stage and extend Quotient's offering.
Sigma-Aldrich is using a novel methodology to create rats with targeted gene deletion in as little as four months, which it believes could eliminate years of research and improve drug development.
Woman’s healthcare and dermatology group Warner Chilcott will unveil plans to buy P&G’s prescription drug division for $3bn (€2.1bn) according to a number of media reports.
Canadian contractor Patheon has welcomed the $460m (€321m) takeover offer from Switzerland's Lonza that could, according to some observers, spark a bidding war with rival suitor, US group JLL Patheon Holdings.
Researchers have presented new microneedle drug delivery patches, which, using technology developed in the electronics sector, could improve compliance and treat ocular diseases.
Outsourcing-Pharma presents its latest round-up of movements in the pharmaceutical outsourcing sector, including appointments at AAIPharma, NextPharma and Catalent.
Xceleron will provide services to GSK and its collaborators, such as academics and biotechs, under a novel deal that emphasises the big pharma’s attempts to change its drug development model.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered the recall of 100 batches of drugs sold by generics firm Karib Kem Pharm.
GEA Lyophil, part of GEA Pharma Systems, has won a contract to supply Chinjese drugmaker Zheijang Hisun Pharmaceutical with freeze drying systems and automatic loading units.
Catalent Pharma Soultions’ pharmaceutical softgels facility in Buenos Aires, Argentina has passed a US Food and Drug Administration (FDA) GMP audit and pre-approval inspection.
US drug giant Pfizer has joined the growing list of organisations seeking to boost trial recruitment via the web, teaming up with IT firm Private Access to create a website designed to “increase clinical trial awareness and participation.”
Researchers claim tobacco plants provide an economical method of manufacturing norovirus vaccine, a product that would have low profit margins, and achieve commercial scale in two to four months.
inVentiv Health is expanding it REMS-related services, which it believes is a growth area, using its experience in risk management to help clients formulate strategies.
Bias in publications in medical journals is facing intense scrutiny again, following media reports GSK used a ghostwriting programme and separate research into combating the problem.
Perrigo’s API business posted a $5.4m (€3.8m) operating loss in Q4 because of restructuring charges but it believes vertically integrating production, and opening a site in India, will help in coming years.
A new partnership between CenterWatch and TrialX may help boost flagging recruitment rates by “helping patients more easily and rapidly connect with relevant clinical trials.”
India-based CRO Vimta Labs is aiming to lower the cost of diagnostic services by developing new panels using MassTag PCR technology licensed from Columbia University, New York.
Datatrak believes that to compete against the eClinical giants companies should focus on a specific niche and hopes this plan will help it post a profit after recording a small loss in Q2.
Australian packaging giant Amcor has offered to buy the European and Asian arms of Alcan Food Packaging along with its pharmaceutical and tobacco businesses for $2025m (€1434m).
Asahikasei’s chemicals unit has launched three new grades of pre-gelatinized starch excipients that it claims have broad application in the control of drug release, stability and disintegration.
PCAS is setting up a kilolab in California, US to target the small-scale synthesis market, which it believes will benefit its large-scale operations by establishing relationships earlier in development.
A dry powder measles vaccine formulation and inhalers that could be as affordable as needle treatments are due to enter Phase I in 2010, according to researchers at the ACS meeting.
US CRO Covance has delayed the construction of a proposed $145m (€102m) preclinical toxicology testing facility at a 47 acre site at the Prince William Technology Park in Virginia.
Generic drugmaker Aurobindo Pharma will add liquid-injectables to its roster of manufacturing capabilities with the purchase of fellow Indian firm Trident Life Sciences (TLSL).
Amcor has temporarily halted trading on the Australian stock exchange, fuelling rumours that the group is finally about to move for Rio Tinto’s Alcan pharmaceutical packaging unit.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Millipore, AM Technology and Alder Pharmaceuticals.
The British pound’s weakness compared to other EU currencies is benefiting UK-based CROs, according to Lab Research (LRI), which attributed the poor performance of its Danish business to the exchange rate.
Medidata has followed its successful IPO by posting an operating profit in Q2, having made a loss last year, and giving a positive outlook for the rest of the year.
Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, US to consolidate its operations in California.
Light Sciences Oncology (LSO) has begun treating the first patient in a Phase I trial of Aptocine (alaporfin sodium), a drug activated by an LED device inserted into a tumour.
Accounting errors related to the purchase of ClinPhone reduced Parexel’s operating income by $15.9m (€11.2m) in fiscal 2009 and the impact of these charges will continue into the next year.
The EMEA has approved Patheon’s facility in Manati, Puerto Rico, allowing the CMO to import to Europe and improving its fortunes on the island that caused it financial problems in the past.
Biotech processes will be improved by using Sani-Tech Ultra tubing, according to its manufacturer that claims the product has a longer lifespan and lower concentration of extractables than its competitors.
Pharsight has launched PKS Online to provide small companies with a PK/PD data and analyses storage system, which it claims saves users money and can improve early-stage development.
Wuxi PharmaTech’s China-based laboratory services grew by 23 per cent in Q2, outstripping expectations and resulting in the company revising its guidance for the business segment.
There has been a blitz of activity at Dendreon following publication of positive trial data, with the company signing two leases for manufacturing facilities and beginning expanding an existing site.
India’s outsourcing sector is growing at 43 per cent, according to a new report that predicts the country will take a bigger share of the global market as concerns about operating there diminish.
Millipore has expanded its European biotech services business by acquiring BioAnaLab, a UK-based company that provides analysis of biologics and vaccines.